A mechanistic model of erythroblast growth inhibition providing a framework for optimisation of cell therapy manufacturing
Manufacture of Red Blood Cell based products in vitro requires highly efficient erythroblast culture for economic viability. It has previously been shown that efficiency of erythroblast culture in scalable bioreactors is not primarily limited by mass transfer, availability of medium components, or c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Default Article |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/32133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|